Cellular senescence and tumor promotion: Is aging the key?

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1865, Issue 2, 2016, Pages 155-167

  Loaiza, Natalia ^a   Demaria, Marco ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b European Research Institute on the Biology of Ageing (ERIBA)   (Netherlands)

Author keywords

Aging; Cancer; Cellular senescence; Premalignant; Pseudo senescence; SASP

Indexed keywords

CHEMOKINE; CYTOKINE; DNA; GROWTH FACTOR; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEINASE; TRANSCRIPTION FACTOR; CHROMATIN; TRANSCRIPTOME;

AGING; CARCINOGENICITY; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA DAMAGE; DNA REPAIR; EPIGENETICS; GENE FUNCTION; GENOMIC INSTABILITY; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNE SYSTEM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; TUMOR PROMOTION; CELL AGING; CHEMISTRY; CHROMATIN; GENETICS; NEOPLASM; ONCOGENE; PATHOLOGY; PHYSIOLOGY;

CELL AGING; CHROMATIN; DNA REPAIR; HUMANS; IMMUNE SYSTEM; NEOPLASMS; NF-KAPPA B; ONCOGENES; TRANSCRIPTOME;

EID: 84960892584     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2016.01.007     Document Type: Review

References (135)

1. D'Aquila P., Rose G., Bellizzi D., Passarino G. Epigenetics and aging. Maturitas 2013, 74:130-136. 10.1016/j.maturitas.2012.11.005.
2. Kirkwood T.B.L. Understanding the odd science of aging. Cell 2005, 120:437-447. 10.1016/j.cell.2005.01.027.
3. Montesanto A., Dato S., Bellizzi D., Rose G., Passarino G. Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun. Ageing A. 2012, 9:6. 10.1186/1742-4933-9-6.
4. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621. 10.1016/0014-4827(61)90192-6.
5. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
6. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522. 10.1016/j.cell.2005.02.003.
7. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602. 10.1016/S0092-8674(00)81902-9.
8. Muñoz-Espín D., Cañamero M., Maraver A., Gómez-López G., Contreras J., Murillo-Cuesta S., et al. Programmed cell senescence during mammalian embryonic development. Cell 2013, 155:1104-1118. 10.1016/j.cell.2013.10.019.
9. Rajagopalan S., Long E.O. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:20596-20601. 10.1073/pnas.1208248109.
10. Storer M., Mas A., Robert-Moreno A., Pecoraro M., Ortells M.C., Di Giacomo V., et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013, 155:1119-1130. 10.1016/j.cell.2013.10.041.
11. Demaria M., Ohtani N., Youssef S.A., Rodier F., Toussaint W., Mitchell J.R., et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 2014, 31:722-733. 10.1016/j.devcel.2014.11.012.
12. Jun J.-I., Lau L.F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 2010, 12:676-685. 10.1038/ncb2070.
13. van Deursen J.M. The role of senescent cells in ageing. Nature 2014, 509:439-446. 10.1038/nature13193.
14. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 2007, 128:36-44. 10.1016/j.mad.2006.11.008.
15. Sherr C.J., DePinho R.A. Cellular senescence: minireview mitotic clock or culture shock?. Cell 2000, 102:407-410. 10.1016/S0092-8674(00)00046-5.
16. Sharpless N.E., Sherr C.J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 2015, 15:397-408. 10.1038/nrc3960.
17. Crescenzi E., Palumbo G., Brady H.J.M. Bcl-2 activates a programme of premature senescence in human carcinoma cells. Biochem. J. 2003, 375:263-274. 10.1042/BJ20030868.
18. Marcotte R., Lacelle C., Wang E. Senescent fibroblasts resist apoptosis by downregulating caspase-3. Mech. Ageing Dev. 2004, 125:777-783. 10.1016/j.mad.2004.07.007.
19. Campisi J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 2013, 75:685-705. 10.1146/annurev-physiol-030212-183653.
20. Campisi J., di Fagagna F.d'Adda Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740. 10.1038/nrm2233.
21. Coppé J.-P., Desprez P.-Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. Mech. Dis. 2010, 5:99-118. 10.1146/annurev-pathol-121808-102144.
22. Lasry A., Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015, 36:217-228. 10.1016/j.it.2015.02.009.
23. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H.F.M., Schlegelberger B., et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436:660-665. 10.1038/nature03841.
24. Chen Z., Trotman L.C., Shaffer D., Lin H.-K., Dotan Z.A., Niki M., et al. Crucial role of p53-dependent cellular senescence in suppression of PTEN-deficient tumorigenesis. Nature 2005, 436:725-730. 10.1038/nature03918.
25. Michaloglou C., Vredeveld L.C.W., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M.A.M., et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724. 10.1038/nature03890.
26. Narita M., Lowe S.W. Senescence comes of age. Nat. Med. 2005, 11:920-922. 10.1038/nm0905-920.
27. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018. 10.1016/j.cell.2008.03.038.
28. Coppe J.-P., Boysen M., Sun C.H., Wong B.J.F., Kang M.K., Park N.-H., et al. A role for fibroblasts in mediating the effects of tobacco-induced epithelial cell growth and invasion. Mol. Cancer Res. 2008, 6:1085-1098. 10.1158/1541-7786.MCR-08-0062.
29. Coppé J.-P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6. 10.1371/journal.pbio.0060301.
30. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12072-12077. 10.1073/pnas.211053698.
31. Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J.L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 2013, 123:966-972. 10.1172/JCI64098.
32. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9363-9367.
33. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236. 10.1038/nature10600.
34. Golomb L., Sagiv A., Pateras I.S., Maly A., Krizhanovsky V., Gorgoulis V.G., et al. Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy. Cell Death Differ. 2015, 22:1764-1774. 10.1038/cdd.2015.21.
35. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217. 10.1016/j.cell.2013.05.039.
36. Pribluda A., Elyada E., Wiener Z., Hamza H., Goldstein R.E., Biton M., et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 2013, 24:242-256. 10.1016/j.ccr.2013.06.005.
37. Kang T.-W., Yevsa T., Woller N., Hoenicke L., Wuestefeld T., Dauch D., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011, 479:547-551. 10.1038/nature10599.
38. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874. 10.1093/carcin/bgh296.
39. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 2012, 14:355-365. 10.1038/ncb2466.
40. Herbig U., Jobling W.A., Chen B.P.C., Chen D.J., Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 2004, 14:501-513.
41. Robles S., Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts 1998, 16. (Publ. Online 04 March 1998 Doi101038sjonc1201862). 10.1038/sj.onc.1201862.
42. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., Barrett J.C. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 2004, 6:168-170. 10.1038/ncb1095.
43. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506. 10.1038/nature01368.
44. Lee J.-S. Activation of ATM-dependent DNA damage signal pathway by a histone deacetylase inhibitor, trichostatin A. Cancer Res. Treat. Off. J. Korean Cancer Assoc. 2007, 39:125-130. 10.4143/crt.2007.39.3.125.
45. Toledo L.I., Murga M., Gutierrez-Martinez P., Soria R., Fernandez-Capetillo O. ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev. 2008, 22:297-302. 10.1101/gad.452308.
46. Colavitti R., Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 2005, 57:277-281. 10.1080/15216540500091890.
47. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., et al. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997, 275:1649-1652.
48. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 1999, 274:7936-7940.
49. Ogrunc M., Di Micco R., Liontos M., Bombardelli L., Mione M., Fumagalli M., et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 2014, 21:998-1012. 10.1038/cdd.2014.16.
50. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637. 10.1038/nature05268.
51. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642. 10.1038/nature05327.
52. Courtois-Cox S., Jones S.L., Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene 2008, 27:2801-2809. 10.1038/sj.onc.1210950.
53. Moiseeva O., Mallette F.A., Mukhopadhyay U.K., Moores A., Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol. Biol. Cell 2006, 17:1583-1592. 10.1091/mbc.E05-09-0858.
54. Munro J., Barr N.I., Ireland H., Morrison V., Parkinson E.K. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp. Cell Res. 2004, 295:525-538. 10.1016/j.yexcr.2004.01.017.
55. Pazolli E., Alspach E., Milczarek A., Prior J., Piwnica-Worms D., Stewart S.A. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res. 2012, 72:2251-2261. 10.1158/0008-5472.CAN-11-3386.
56. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 1998, 12:3008-3019.
57. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic raf. Genes Dev. 1998, 12:2997-3007. 10.1101/gad.12.19.2997.
58. Takeuchi S., Takahashi A., Motoi N., Yoshimoto S., Tajima T., Yamakoshi K., et al. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res. 2010, 70:9381-9390. 10.1158/0008-5472.CAN-10-0801.
59. Freund A., Patil C.K., Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011, 30:1536-1548. 10.1038/emboj.2011.69.
60. Passos J.F., Nelson G., Wang C., Richter T., Simillion C., Proctor C.J., et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 2010, 6:347. 10.1038/msb.2010.5.
61. Adams P.D. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol. Cell 2009, 36:2-14. 10.1016/j.molcel.2009.09.021.
62. Bracken A.P., Kleine-Kohlbrecher D., Dietrich N., Pasini D., Gargiulo G., Beekman C., et al. The polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007, 21:525-530. 10.1101/gad.415507.
63. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(arf) pathway. Nat. Genet. 2004, 36:343-350. 10.1038/ng1317.
64. Deng Q., Liao R., Wu B.-L., Sun P. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J. Biol. Chem. 2004, 279:1050-1059. 10.1074/jbc.M308644200.
65. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12:446-451. 10.1038/nm1388.
66. Olsen C.L., Gardie B., Yaswen P., Stampfer M.R. Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene 2002, 21:6328-6339. 10.1038/sj.onc.1205780.
67. Lee B.Y., Han J.A., Im J.S., Morrone A., Johung K., Goodwin E.C., et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 2006, 5:187-195. 10.1111/j.1474-9726.2006.00199.x.
68. Reddy K.L., Zullo J.M., Bertolino E., Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 2008, 452:243-247. 10.1038/nature06727.
69. Freund A., Laberge R.-M., Demaria M., Campisi J. Lamin B1 loss is a senescence-associated biomarker. Mol. Biol. Cell 2012, 23:2066-2075. 10.1091/mbc.E11-10-0884.
70. Mehta I.S., Figgitt M., Clements C.S., Kill I.R., Bridger J.M. Alterations to nuclear architecture and genome behavior in senescent cells. Ann. N. Y. Acad. Sci. 2007, 1100:250-263. 10.1196/annals.1395.027.
71. Zhang R., Chen W., Adams P.D. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol. Cell. Biol. 2007, 27:2343-2358. 10.1128/MCB.02019-06.
72. Davalos A.R., Kawahara M., Malhotra G.K., Schaum N., Huang J., Ved U., et al. p53-dependent release of alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 2013, 201:613-629. 10.1083/jcb.201206006.
73. Nakamura A.J., Chiang Y.J., Hathcock K.S., Horikawa I., Sedelnikova O.A., Hodes R.J., et al. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 2008, 1:6. 10.1186/1756-8935-1-6.
74. Narita M., Nuñez S., Heard E., Narita M., Lin A.W., Hearn S.A., et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716. 10.1016/S0092-8674(03)00401-X.
75. Kosar M., Bartkova J., Hubackova S., Hodny Z., Lukas J., Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle Georget. Tex. 2011, 10:457-468.
76. Shah P.P., Donahue G., Otte G.L., Capell B.C., Nelson D.M., Cao K., et al. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev. 2013, 27:1787-1799. 10.1101/gad.223834.113.
77. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707. 10.1038/366704a0.
78. Ohtani N., Yamakoshi K., Takahashi A., Hara E. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J. Med. Investig. 2004, 51:146-153.
79. Demaria M., Desprez P.Y., Campisi J., Velarde M.C. Cell autonomous and non-autonomous effects of senescent cells in the skin. J. Invest. Dermatol. 2015, 135:1722-1726. 10.1038/jid.2015.108.
80. Kuilman T., Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 2009, 9:81-94. 10.1038/nrc2560.
81. Coppé J.-P., Rodier F., Patil C.K., Freund A., Desprez P.-Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 2011, 286:36396-36403. 10.1074/jbc.M111.257071.
82. Coppé J.-P., Patil C.K., Rodier F., Krtolica A., Beauséjour C.M., Parrinello S., et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE 2010, 5. 10.1371/journal.pone.0009188.
83. Rodier F., Coppé J.-P., Patil C.K., Hoeijmakers W.A.M., Muñoz D.P., Raza S.R., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 2009, 11:973-979. 10.1038/ncb1909.
84. Kang C., Xu Q., Martin T.D., Li M.Z., Demaria M., Aron L., et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 2015, 349:aaa5612. 10.1126/science.aaa5612.
85. Kuilman T., Michaloglou C., Vredeveld L.C.W., Douma S., van Doorn R., Desmet C.J., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031. 10.1016/j.cell.2008.03.039.
86. Wajapeyee N., Serra R.W., Zhu X., Mahalingam M., Green M.R. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008, 132:363-374. 10.1016/j.cell.2007.12.032.
87. Yang G., Rosen D.G., Zhang Z., Bast R.C., Mills G.B., Colacino J.A., et al. The chemokine growth-regulated oncogene 1 (gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16472-16477. 10.1073/pnas.0605752103.
88. Binet R., Ythier D., Robles A.I., Collado M., Larrieu D., Fonti C., et al. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2009, 69:9183-9191. 10.1158/0008-5472.CAN-09-1016.
89. Cahu J., Bustany S., Sola B. Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. Cell Death Dis. 2012, 3. 10.1038/cddis.2012.183.
90. Acosta J.C., Banito A., Wuestefeld T., Georgilis A., Janich P., Morton J.P., et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 2013, 15:978-990. 10.1038/ncb2784.
91. Prise K.M., O'Sullivan J.M. Radiation-induced bystander signalling in cancer therapy. Nat. Rev. Cancer 2009, 9:351-360. 10.1038/nrc2603.
92. Burd C.E., Sorrentino J.A., Clark K.S., Darr D.B., Krishnamurthy J., Deal A.M., et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 2013, 152:340-351. 10.1016/j.cell.2012.12.010.
93. Ancrile B., Lim K.-H., Counter C.M. Oncogenic ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 2007, 21:1714-1719. 10.1101/gad.1549407.
94. Naugler W.E., Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 2008, 14:109-119. 10.1016/j.molmed.2007.12.007.
95. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458. 10.1016/j.ccr.2004.09.028.
96. Blank C., Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol. Immunother. 2007, 56:739-745. 10.1007/s00262-006-0272-1.
97. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435. 10.1038/nature07201.
98. Davalos A.R., Coppe J.-P., Campisi J., Desprez P.-Y. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 2010, 29:273-283. 10.1007/s10555-010-9220-9.
99. Moogk D., da Silva I.P., Ma M.W., Friedman E.B., de Miera E.V.-S., Darvishian F., et al. Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. J. Transl. Med. 2014, 12. 10.1186/s12967-014-0342-7.
100. Yu T.-Y., Pang J.-H.S., Wu K.P.-H., Chen M.J.-L., Chen C.-H., Tsai W.-C. Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes. BMC Musculoskelet. Disord. 2013, 14:2. 10.1186/1471-2474-14-2.
101. Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 2012, 12:252-264. 10.1038/nrc3239.
102. Adler A.S., Sinha S., Kawahara T.L.A., Zhang J.Y., Segal E., Chang H.Y. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 2007, 21:3244-3257. 10.1101/gad.1588507.
103. Rando T.A., Chang H.Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 2012, 148:46-57. 10.1016/j.cell.2012.01.003.
104. Tilstra J.S., Robinson A.R., Wang J., Gregg S.Q., Clauson C.L., Reay D.P., et al. NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 2012, 122:2601-2612. 10.1172/JCI45785.
105. Chien Y., Scuoppo C., Wang X., Fang X., Balgley B., Bolden J.E., et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 2011, 25:2125-2136. 10.1101/gad.17276711.
106. Laberge R.-M., Sun Y., Orjalo A.V., Patil C.K., Freund A., Zhou L., et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol. 2015, 17:1049-1061. 10.1038/ncb3195.
107. Zoncu R., Sabatini D.M., Efeyan A. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011, 12:21-35. 10.1038/nrm3025.
108. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660. 10.1038/nature05529.
109. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667. 10.1016/j.cell.2008.06.049.
110. Oh J., Lee Y.D., Wagers A.J. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 2014, 20:870-880. 10.1038/nm.3651.
111. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 1986, 315:1650-1659. 10.1056/NEJM198612253152606.
112. Riss J., Khanna C., Koo S., Chandramouli G.V.R., Yang H.H., Hu Y., et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res. 2006, 66:7216-7224. 10.1158/0008-5472.CAN-06-0040.
113. Hoenicke L., Zender L. Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis 2012, bgs124. 10.1093/carcin/bgs124.
114. Gorbunova V., Seluanov A., Mao Z., Hine C. Changes in DNA repair during aging. Nucleic Acids Res. 2007, 35:7466-7474. 10.1093/nar/gkm756.
115. Krejci L., Altmannova V., Spirek M., Zhao X. Homologous recombination and its regulation. Nucleic Acids Res. 2012, gks270. 10.1093/nar/gks270.
116. Mao Z., Tian X., Van Meter M., Ke Z., Gorbunova V., Seluanov A. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:11800-11805. 10.1073/pnas.1200583109.
117. Davis A.J., Chen D.J. DNA double strand break repair via non-homologous end-joining. Transl. Cancer Res. 2013, 2:130-143. 10.3978/j.issn.2218-676X.2013.04.02.
118. Seluanov A., Mittelman D., Pereira-Smith O.M., Wilson J.H., Gorbunova V. DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7624-7629. 10.1073/pnas.0400726101.
119. Beauséjour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 2003, 22:4212-4222. 10.1093/emboj/cdg417.
120. Busuttil R.A., Rubio M., Dollé M.E.T., Campisi J., Vijg J. Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic lacZ-plasmid reporter mice. DNA Repair 2006, 5:52-60. 10.1016/j.dnarep.2005.07.006.
121. Busuttil R.A., Rubio M., Dollé M.E.T., Campisi J., Vijg J. Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell 2003, 2:287-294.
122. Xu Z., Zhang L., Zhang W., Meng D., Zhang H., Jiang Y., et al. SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner. Cell Cycle Georget. Tex. 2015, 14:269-276. 10.4161/15384101.2014.980641.
123. Nagai K., Matsushita T., Matsuzaki T., Takayama K., Matsumoto T., Kuroda R., et al. Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes. Osteoarthr. Cartil. 2015, 23:1412-1420. 10.1016/j.joca.2015.03.024.
124. Wu Y., Chen L., Wang Y., Li W., Lin Y., Yu D., et al. Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development. Sci. Rep. 2015, 5. 10.1038/srep17602.
125. Serrano M. Cancer: final act of senescence. Nature 2011, 479:481-482. 10.1038/479481a.
126. Damsky W., Micevic G., Meeth K., Muthusamy V., Curley D.P., Santhanakrishnan M., et al. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. Cancer Cell 2015, 27:41-56. 10.1016/j.ccell.2014.11.014.
127. Vredeveld L.C.W., Possik P.A., Smit M.A., Meissl K., Michaloglou C., Horlings H.M., et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012, 26:1055-1069. 10.1101/gad.187252.112.
128. Souroullas G.P., Sharpless N.E. mTOR signaling in melanoma: oncogene-induced pseudo-senescence?. Cancer Cell 2015, 27:3-5. 10.1016/j.ccell.2014.12.005.
129. Webster M.R., Xu M., Kinzler K.A., Kaur A., Appleton J., O'Connell M.P., et al. Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res. 2015, 28:184-195. 10.1111/pcmr.12330.
130. Demidenko Z.N., Blagosklonny M.V. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle Georget. Tex. 2008, 7:3355-3361.
131. Leontieva O.V., Natarajan V., Demidenko Z.N., Burdelya L.G., Gudkov A.V., Blagosklonny M.V. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13314-13318. 10.1073/pnas.1205690109.
132. Aird K.M., Worth A.J., Snyder N.W., Lee J.V., Sivanand S., Liu Q., et al. ATM couples replication stress and metabolic reprogramming during cellular senescence. Cell Rep. 2015, 11:893-901. 10.1016/j.celrep.2015.04.014.
133. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., et al. Tumour biology: senescence in premalignant tumours. Nature 2005, 436:642. 10.1038/436642a.
134. Cruickshanks H.A., McBryan T., Nelson D.M., VanderKraats N.D., Shah P.P., van Tuyn J., et al. Senescent cells harbour features of the cancer epigenome. Nat. Cell Biol. 2013, 15:1495-1506. 10.1038/ncb2879.
135. Goronzy J.J., Weyand C.M. Understanding immunosenescence to improve responses to vaccines. Nat. Immunol. 2013, 14:428-436. 10.1038/ni.2588.